SINGAPORE (The Straits Times/Asia News Network): People who received two doses of China's Sinovac vaccine were more likely to develop severe disease from Covid-19 than those who got two shots of the mRNA-based Pfizer-BioNTech or Moderna vaccines, the National Centre for Infectious Diseases (NCID) has found.
"This supports the need for three doses of Sinovac-CoronaVac vaccine as a primary series," it said in a statement on Wednesday (Dec 15).
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!